Biotech Values

[vinmantoo]

GSK/IONS—Bepirovirsen phase-3 trials hit_primary_endpoint_of HBV functional cure:

Good to see progress being made in Hep B. Still, how much better than standard of care these new data shows. I kept fantasizing that ENTA's Hep B drug EDP-514 would fine a role in a partnership but that remains a pipedream.